Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	fatty-acyl-CoA synthase activity	ACSM3 ACSM2A ACSM2B	8.93e-06	8	110	3	GO:0004321
GeneOntologyMolecularFunction	medium-chain fatty acid-CoA ligase activity	ACSM3 ACSM2A ACSM2B	2.60e-05	11	110	3	GO:0031956
GeneOntologyMolecularFunction	benzoate-CoA ligase activity	ACSM2A ACSM2B	8.99e-05	3	110	2	GO:0018858
GeneOntologyMolecularFunction	decanoate-CoA ligase activity	ACSM2A ACSM2B	1.79e-04	4	110	2	GO:0102391
GeneOntologyMolecularFunction	C-acyltransferase activity	ACSM3 ACSM2A ACSM2B	2.01e-04	21	110	3	GO:0016408
GeneOntologyMolecularFunction	fatty acid ligase activity	ACSM3 ACSM2A ACSM2B	3.86e-04	26	110	3	GO:0015645
GeneOntologyMolecularFunction	CoA-ligase activity	ACSM3 ACSM2A ACSM2B	4.32e-04	27	110	3	GO:0016405
GeneOntologyMolecularFunction	acid-thiol ligase activity	ACSM3 ACSM2A ACSM2B	6.53e-04	31	110	3	GO:0016878
GeneOntologyMolecularFunction	structural constituent of presynaptic active zone	PCLO RIMS1	8.24e-04	8	110	2	GO:0098882
Domain	FN3	EPHB4 COL6A3 COL7A1 FN1 VASN IGDCC4 PTPRS TNXB	9.12e-06	185	104	8	SM00060
Domain	FN3	EPHB4 COL6A3 COL7A1 FN1 VASN IGDCC4 PTPRS TNXB	1.55e-05	199	104	8	PS50853
Domain	FN3_dom	EPHB4 COL6A3 COL7A1 FN1 VASN IGDCC4 PTPRS TNXB	2.21e-05	209	104	8	IPR003961
Domain	fn3	EPHB4 COL7A1 FN1 VASN IGDCC4 PTPRS TNXB	3.40e-05	162	104	7	PF00041
Domain	EGF-like_CS	EPHB4 HSPG2 FN1 VASN ADAM29 CELSR2 CNTNAP2 TNXB	1.06e-04	261	104	8	IPR013032
Domain	AMP-bd_C	ACSM3 ACSM2A ACSM2B	1.08e-04	17	104	3	IPR025110
Domain	AMP-binding_C	ACSM3 ACSM2A ACSM2B	1.08e-04	17	104	3	PF13193
Domain	-	IGSF8 EPHB4 HSPG2 COL6A3 COL7A1 FN1 TAPBPL VASN DAG1 IGDCC4 PTPRS TNXB	3.17e-04	663	104	12	2.60.40.10
Domain	AMP-binding_CS	ACSM3 ACSM2A ACSM2B	3.97e-04	26	104	3	IPR020845
Domain	MCM_N	MCM5 MCM7	4.54e-04	6	104	2	PF14551
Domain	MCM_CS	MCM5 MCM7	4.54e-04	6	104	2	IPR018525
Domain	MCM_N	MCM5 MCM7	4.54e-04	6	104	2	IPR027925
Domain	Cadherin-like	PCDHB2 DAG1 PCDH17 CELSR2 PCDH7	4.78e-04	116	104	5	IPR015919
Domain	AMP_BINDING	ACSM3 ACSM2A ACSM2B	4.97e-04	28	104	3	PS00455
Domain	Ig-like_fold	IGSF8 EPHB4 HSPG2 COL6A3 COL7A1 FN1 TAPBPL VASN DAG1 IGDCC4 PTPRS TNXB	5.57e-04	706	104	12	IPR013783
Domain	EGF_1	HSPG2 FN1 VASN ADAM29 CELSR2 CNTNAP2 TNXB	5.62e-04	255	104	7	PS00022
Domain	AMP-binding	ACSM3 ACSM2A ACSM2B	6.10e-04	30	104	3	PF00501
Domain	AMP-dep_Synth/Lig	ACSM3 ACSM2A ACSM2B	6.10e-04	30	104	3	IPR000873
Domain	EGF	HSPG2 VASN CELSR2 CNTNAP2 TNXB	6.96e-04	126	104	5	PF00008
Domain	EGF_2	EPHB4 HSPG2 VASN ADAM29 CELSR2 CNTNAP2 TNXB	7.05e-04	265	104	7	PS01186
Domain	MCM_OB	MCM5 MCM7	8.41e-04	8	104	2	PF17207
Domain	MCM_OB	MCM5 MCM7	8.41e-04	8	104	2	IPR033762
Domain	MCM_2	MCM5 MCM7	8.41e-04	8	104	2	PS50051
Domain	MCM_1	MCM5 MCM7	8.41e-04	8	104	2	PS00847
Domain	MFS_1	SPNS1 SLC43A1 SLC16A5 SLC17A8	8.99e-04	77	104	4	PF07690
Domain	MFS	SPNS1 SLC43A1 SLC16A5 SLC17A8	8.99e-04	77	104	4	IPR011701
Domain	MCM	MCM5 MCM7	1.08e-03	9	104	2	SM00350
Domain	MCM_dom	MCM5 MCM7	1.08e-03	9	104	2	IPR001208
Domain	MCM	MCM5 MCM7	1.08e-03	9	104	2	IPR031327
Domain	MCM	MCM5 MCM7	1.08e-03	9	104	2	PF00493
Domain	LAM_G_DOMAIN	HSPG2 CELSR2 CNTNAP2	1.23e-03	38	104	3	PS50025
Domain	Laminin_G_2	HSPG2 CELSR2 CNTNAP2	1.43e-03	40	104	3	PF02210
Domain	LamG	HSPG2 CELSR2 CNTNAP2	1.88e-03	44	104	3	SM00282
Domain	EGF_3	HSPG2 VASN ADAM29 CELSR2 CNTNAP2 TNXB	2.03e-03	235	104	6	PS50026
Domain	uDENN	DENND1A MADD	2.68e-03	14	104	2	SM00800
Domain	EGF-like_dom	HSPG2 VASN ADAM29 CELSR2 CNTNAP2 TNXB	2.70e-03	249	104	6	IPR000742
Domain	uDENN	DENND1A MADD	3.08e-03	15	104	2	PF03456
Domain	Cadherin_CS	PCDHB2 PCDH17 CELSR2 PCDH7	3.23e-03	109	104	4	IPR020894
Domain	DENN	DENND1A MADD	3.50e-03	16	104	2	SM00799
Domain	DENN	DENND1A MADD	3.50e-03	16	104	2	PF02141
Domain	dDENN	DENND1A MADD	3.50e-03	16	104	2	PF03455
Domain	UDENN	DENND1A MADD	3.50e-03	16	104	2	PS50946
Domain	DDENN	DENND1A MADD	3.50e-03	16	104	2	PS50947
Domain	dDENN	DENND1A MADD	3.50e-03	16	104	2	SM00801
Domain	dDENN_dom	DENND1A MADD	3.50e-03	16	104	2	IPR005112
Domain	uDENN_dom	DENND1A MADD	3.50e-03	16	104	2	IPR005113
Domain	DENN	DENND1A MADD	3.50e-03	16	104	2	PS50211
Domain	DENN_dom	DENND1A MADD	3.50e-03	16	104	2	IPR001194
Domain	CADHERIN_1	PCDHB2 PCDH17 CELSR2 PCDH7	3.67e-03	113	104	4	PS00232
Domain	Cadherin	PCDHB2 PCDH17 CELSR2 PCDH7	3.67e-03	113	104	4	PF00028
Domain	CADHERIN_2	PCDHB2 PCDH17 CELSR2 PCDH7	3.79e-03	114	104	4	PS50268
Domain	-	PCDHB2 PCDH17 CELSR2 PCDH7	3.79e-03	114	104	4	2.60.40.60
Domain	CA	PCDHB2 PCDH17 CELSR2 PCDH7	3.91e-03	115	104	4	SM00112
Domain	Laminin_G	HSPG2 CELSR2 CNTNAP2	4.14e-03	58	104	3	IPR001791
Domain	Cadherin	PCDHB2 PCDH17 CELSR2 PCDH7	4.28e-03	118	104	4	IPR002126
Domain	-	COL6A3 COL7A1	4.43e-03	18	104	2	4.10.410.10
Domain	Prtase_inh_Kunz-CS	COL6A3 COL7A1	4.43e-03	18	104	2	IPR020901
Domain	BPTI_KUNITZ_1	COL6A3 COL7A1	4.94e-03	19	104	2	PS00280
Domain	BPTI_KUNITZ_2	COL6A3 COL7A1	4.94e-03	19	104	2	PS50279
Domain	Kunitz_BPTI	COL6A3 COL7A1	4.94e-03	19	104	2	PF00014
Pathway	REACTOME_ECM_PROTEOGLYCANS	HSPG2 COL6A3 FN1 DAG1 PTPRS TNXB	5.46e-06	76	83	6	M27219
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPHB4 HSPG2 SETD1B MCM5 ANKLE1 KAT2A MED13L DENND1A MADD TAOK2 CELSR2 SLC16A5 ARVCF PTPRS PLEKHO2 MTHFR EIF4G1 PALM SNAPC4	2.55e-09	1105	112	19	35748872
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ZC3H14 NOL6 PUM2 MCM5 KAT2A MORC2 KANK2 ALKBH5 DENND1A MFF TAOK2 MDC1 EIF4G1 PWP2 MIOS PALM3 MACF1 YME1L1 USP6NL MAN1B1	6.24e-08	1497	112	20	31527615
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ZC3H14 TBC1D15 TNFSF14 NOL6 SMC6 NASP MORC2 TRIM24 KANK2 PNPT1 MDC1 SYNE2 EIF4G1 YME1L1	1.52e-07	754	112	14	35906200
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	IGSF8 EPHB4 TAPBPL NHSL2 MADD ACSM3 PLEKHO2 CSNK1G3 OASL PALM MACF1 NBR1 USP6NL	5.89e-07	719	112	13	35337019
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	EPHB4 NR2C2 SPNS1 TBC1D15 VARS2 TRIM24 KANK2 TUBGCP6 PNPT1 GLS SYNE2 PWP2 PALM MACF1 YME1L1 PCDH7 NBR1 USP6NL	1.28e-06	1487	112	18	33957083
Pubmed	Mice develop normally without tenascin.	HSPG2 FN1 TNXB	1.80e-06	8	112	3	1383086
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	HSPG2 COL6A3 COL7A1 FN1 TNXB	2.07e-06	64	112	5	22261194
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	PUM2 MADD TAOK2 AP2M1 CNTNAP2 MACF1	4.20e-06	130	112	6	12421765
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	ZC3H14 PUM2 MCM5 MCM7 KANK2 CRYAB EIF4G1 MACF1	8.71e-06	315	112	8	26777405
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZC3H14 FN1 NOL6 MCM5 PNPT1 MDC1 SYNE2 EIF4G1 PWP2 OASL MACF1	8.88e-06	653	112	11	22586326
Pubmed	Timeless links replication termination to mitotic kinase activation.	SMC6 MCM5 MCM7	9.08e-06	13	112	3	21573113
Pubmed	Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix.	COL7A1 FN1	1.03e-05	2	112	2	7963647
Pubmed	Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines.	ACSM2A ACSM2B	1.03e-05	2	112	2	19634011
Pubmed	Expression, nuclear localization and interactions of human MCM/P1 proteins.	MCM5 MCM7	1.03e-05	2	112	2	9223437
Pubmed	Differential deposition of basement membrane components during formation of the caudal neural tube in the mouse embryo.	HSPG2 FN1	1.03e-05	2	112	2	3665768
Pubmed	Genome-wide analyses of human perisylvian cerebral cortical patterning.	PCDH17 CNTNAP2	1.03e-05	2	112	2	17978184
Pubmed	The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population.	ACSM2A ACSM2B	1.03e-05	2	112	2	16521160
Pubmed	Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.	ACSM2A ACSM2B	1.03e-05	2	112	2	29948332
Pubmed	Deletion of astroglial connexins weakens the blood-brain barrier.	HSPG2 FN1 DAG1	1.15e-05	14	112	3	22472609
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	VGF NHSL2 KANK2 TAOK2 CELSR2 ARVCF PTPRS SYNE2 EIF4G1 MIOS MACF1 RIMS1 TACC3	1.41e-05	963	112	13	28671696
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IGSF8 FN1 PCLO KANK2 MADD CRYAB MLXIPL AP2M1 NWD2 ARVCF PTPRS EIF4G1 MIOS PALM MACF1 RIMS1	1.43e-05	1431	112	16	37142655
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	CAMK1D VASN DAG1 KANK2 ARVCF PLEKHO2 EIF4G1 PALM3 MACF1 USP6NL	1.52e-05	565	112	10	25468996
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	NHSL2 PCLO NOL6 MCM5 KAT2A NEB AP2M1 ACSM3 GLS SYNE2 EIF4G1 PWP2 PALM MACF1 RIMS1 CFAP46	1.57e-05	1442	112	16	35575683
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	HSPG2 COL6A3 FN1 DAG1 TNXB	1.61e-05	97	112	5	27559042
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	HSPG2 FN1 DAG1	1.77e-05	16	112	3	17948866
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	MORC2 TAOK2 TTBK2 GLS CNTNAP2	1.87e-05	100	112	5	10048485
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	ZC3H14 TBC1D15 MORC2 KANK2 MFF TAB3 MADD AP2M1 YME1L1 NBR1	2.68e-05	604	112	10	38803224
Pubmed	The minichromosome maintenance proteins 2-7 (MCM2-7) are necessary for RNA polymerase II (Pol II)-mediated transcription.	MCM5 MCM7	3.08e-05	3	112	2	19318354
Pubmed	The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids.	MCM5 MCM7	3.08e-05	3	112	2	34449552
Pubmed	Immunohistochemical localization of syndecan-1 in the dental follicle of postnatal mouse teeth.	HSPG2 FN1	3.08e-05	3	112	2	17608588
Pubmed	Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.	HSPG2 FN1	3.08e-05	3	112	2	19553700
Pubmed	Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.	HSPG2 DAG1	3.08e-05	3	112	2	16098969
Pubmed	Targeted inhibition of the expression of both MCM5 and MCM7 by miRNA-214 impedes DNA replication and tumorigenesis in hepatocellular carcinoma cells.	MCM5 MCM7	3.08e-05	3	112	2	35490917
Pubmed	Reciprocal expressions between α-dystroglycan and integrin β1, perlecan receptors, in the murine enamel organ development.	HSPG2 DAG1	3.08e-05	3	112	2	23722005
Pubmed	Expression of tenascin in developing and adult mouse lymphoid organs.	FN1 TNXB	3.08e-05	3	112	2	7687262
Pubmed	Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.	AP2M1 EIF4G1	3.08e-05	3	112	2	17290396
Pubmed	Differential expression profiles between α-dystroglycan and integrin β1 in ameloblastoma: two possible perlecan signalling pathways for cellular growth and differentiation.	HSPG2 DAG1	3.08e-05	3	112	2	21255062
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	ZC3H14 KAT2A MORC2 ALKBH5 PWP2 MIOS MACF1	3.67e-05	281	112	7	24163370
Pubmed	Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways.	FN1 EIF4G1	6.14e-05	4	112	2	15961545
Pubmed	Minichromosome maintenance (MCM) and AgNOR proteins expression in desmoid tumours: a tissue microarray analysis.	MCM5 MCM7	6.14e-05	4	112	2	21478101
Pubmed	MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.	NR2C2 TAB3	6.14e-05	4	112	2	24565101
Pubmed	Genetic mapping of the mouse neuromuscular mutation kyphoscoliosis.	COL7A1 DAG1	6.14e-05	4	112	2	7774920
Pubmed	The P1 family: a new class of nuclear mammalian proteins related to the yeast Mcm replication proteins.	MCM5 MCM7	6.14e-05	4	112	2	8265339
Pubmed	PNPT1, MYO15A, PTPRQ, and SLC12A2-associated genetic and phenotypic heterogeneity among hearing impaired assortative mating families in Southern India.	PNPT1 PTPRQ	6.14e-05	4	112	2	34374074
Pubmed	Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication.	MCM5 MCM7	6.14e-05	4	112	2	19377303
Pubmed	Expression of Acsm2, a kidney-specific gene, parallels the function and maturation of proximal tubular cells.	ACSM2A ACSM2B	6.14e-05	4	112	2	32830538
Pubmed	Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.	HSPG2 DAG1	6.14e-05	4	112	2	25646087
Pubmed	Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen.	COL6A3 TNXB	6.14e-05	4	112	2	15194424
Pubmed	Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.	MCM5 MCM7	6.14e-05	4	112	2	30842144
Pubmed	Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.	MLXIPL ACSM3 CELSR2 ACSM2B	6.30e-05	66	112	4	20679960
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	DAG1 CELSR2 ARVCF CSNK1G3 PALM MACF1 PCDH7 USP6NL	6.85e-05	421	112	8	36976175
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	HSPG2 FN1 NEB PLEKHO2 PWP2 PCDH7	7.04e-05	214	112	6	22199357
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	HSPG2 COL6A3 COL7A1 FN1 TNXB	7.87e-05	135	112	5	28675934
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	TMEM202 TBC1D15 SETD1B PUM2 KAT2A MED13L GLS SLC17A8	8.06e-05	431	112	8	33660365
Pubmed	Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996.	COL6A3 FN1 NEB GLS	8.38e-05	71	112	4	8751373
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	FN1 NASP NEB TRIM24 MFF SYNE2 MACF1	8.62e-05	322	112	7	26514267
Pubmed	M-Phase Phosphoprotein 9 regulates ciliogenesis by modulating CP110-CEP97 complex localization at the mother centriole.	KIF24 TTBK2	1.02e-04	5	112	2	30375385
Pubmed	A nontranscriptional role for HIF-1α as a direct inhibitor of DNA replication.	MCM5 MCM7	1.02e-04	5	112	2	23405012
Pubmed	Spatial and temporal changes in chondroitin sulfate distribution in the sclerotome play an essential role in the formation of migration patterns of mouse neural crest cells.	HSPG2 FN1	1.02e-04	5	112	2	9915576
Pubmed	Disruption of the talin gene arrests mouse development at the gastrulation stage.	HSPG2 FN1	1.02e-04	5	112	2	11084655
Pubmed	TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.	NR2C2 TAB3	1.02e-04	5	112	2	32229191
Pubmed	Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan.	HSPG2 FN1	1.02e-04	5	112	2	11493006
Pubmed	Molecular architecture of the human GINS complex.	MCM5 MCM7	1.02e-04	5	112	2	17557111
Pubmed	Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin.	COL7A1 FN1	1.02e-04	5	112	2	9169408
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	HSPG2 COL7A1 FN1	1.12e-04	29	112	3	22613833
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	HSPG2 COL6A3 FN1 DAG1 TNXB	1.14e-04	146	112	5	27068509
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHB2 PCDH17 CELSR2 PCDH7	1.15e-04	77	112	4	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHB2 PCDH17 CELSR2 PCDH7	1.33e-04	80	112	4	10716726
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	HSPG2 COL6A3 COL7A1 FN1 TNXB	1.42e-04	153	112	5	25037231
Pubmed	Human Mcm proteins at a replication origin during the G1 to S phase transition.	MCM5 MCM7	1.53e-04	6	112	2	12364596
Pubmed	A protein interaction node at the neurotransmitter release site: domains of Aczonin/Piccolo, Bassoon, CAST, and rim converge on the N-terminal domain of Munc13-1.	PCLO RIMS1	1.53e-04	6	112	2	19812333
Pubmed	The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin.	HSPG2 FN1	1.53e-04	6	112	2	11956183
Pubmed	The IA-2 interactome.	MADD PTPRS	1.53e-04	6	112	2	16273344
Pubmed	Pairwise interactions of the six human MCM protein subunits.	MCM5 MCM7	1.53e-04	6	112	2	15236977
Pubmed	Highly stable loading of Mcm proteins onto chromatin in living cells requires replication to unload.	MCM5 MCM7	1.53e-04	6	112	2	21220507
Pubmed	A role for USP7 in DNA replication.	MCM5 MCM7	1.53e-04	6	112	2	24190967
Pubmed	Physical and functional interaction of the active zone proteins, CAST, RIM1, and Bassoon, in neurotransmitter release.	PCLO RIMS1	1.53e-04	6	112	2	14734538
Pubmed	The eukaryotic Mcm2-7 replicative helicase.	MCM5 MCM7	1.53e-04	6	112	2	22918583
Pubmed	In vivo interaction of human MCM heterohexameric complexes with chromatin. Possible involvement of ATP.	MCM5 MCM7	1.53e-04	6	112	2	9099751
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	HSPG2 COL6A3 FN1 TNXB	1.77e-04	86	112	4	28327460
Pubmed	Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.	MADD MLXIPL CELSR2	1.81e-04	34	112	3	19060911
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	HSPG2 COL6A3 FN1 VASN PTPRS TNXB	1.91e-04	257	112	6	16335952
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TBC1D15 PCLO NOL6 SMC6 NASP MCM5 MCM7 RIC8B AP2M1 MDC1 GLS EIF4G1 PWP2 NBR1	1.99e-04	1425	112	14	30948266
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NASP PUM2 MORC2 TUBGCP6 MDC1 EIF4G1 RIMS1 TACC3 SNAPC4 PCDH7	2.07e-04	774	112	10	15302935
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	HSPG2 COL6A3 FN1 NEB CRYAB SYNE2 MACF1 ZNF417	2.13e-04	497	112	8	23414517
Pubmed	O-GlcNAc transferase associates with the MCM2-7 complex and its silencing destabilizes MCM-MCM interactions.	MCM5 MCM7	2.14e-04	7	112	2	30069701
Pubmed	Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation.	NR2C2 TAB3	2.14e-04	7	112	2	22158122
Pubmed	Identification and characterization of a novel component of the human minichromosome maintenance complex.	MCM5 MCM7	2.14e-04	7	112	2	17296731
Pubmed	Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17.	MCM5 MCM7	2.14e-04	7	112	2	19150984
Pubmed	alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.	COL7A1 FN1	2.14e-04	7	112	2	9151677
Pubmed	Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-gamma.	MCM5 MCM7	2.14e-04	7	112	2	11248027
Pubmed	The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases.	KAT2A TACC3	2.14e-04	7	112	2	14767476
Pubmed	Interaction of chromatin-associated Plk1 and Mcm7.	MCM5 MCM7	2.14e-04	7	112	2	15654075
Pubmed	Binding of human minichromosome maintenance proteins with histone H3.	MCM5 MCM7	2.14e-04	7	112	2	8798650
Pubmed	Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice.	HSPG2 FN1	2.14e-04	7	112	2	12242711
Pubmed	Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers.	MCM5 MCM7	2.14e-04	7	112	2	23764002
Pubmed	Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.	HSPG2 DAG1	2.14e-04	7	112	2	11802174
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NOL6 NAP1L3 NEB TRIM24 TTBK2 ARVCF GLS SYNE2 YME1L1	2.29e-04	638	112	9	31182584
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZC3H14 NR2C2 MCM5 MCM7 KAT2A MED13L MORC2 TRIM24 ALKBH5 E2F8 AP2M1 RASGRP2	2.34e-04	1103	112	12	34189442
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	TBC1D15 MFF MADD SYNE2 TMED8 MIOS YME1L1 PCDH7	2.35e-04	504	112	8	34432599
Interaction	CDH16 interactions	DAG1 TRIM24 CRYAB CELSR2 PTPRS	4.11e-07	28	111	5	int:CDH16
Interaction	ACSM2A interactions	ACSM3 ACSM2A ACSM2B	6.48e-07	4	111	3	int:ACSM2A
Interaction	RHOC interactions	EPHB4 ZC3H14 VASN NOL6 DAG1 CCDC187 MFF PCDH17 AP2M1 PTPRS CSNK1G3 SYNE2 PALM MACF1 PCDH7	7.46e-07	584	111	15	int:RHOC
Interaction	PCDH12 interactions	PCDH17 CELSR2 PTPRS PCDH7	5.91e-06	22	111	4	int:PCDH12
Interaction	TMEM30B interactions	IGSF8 PCDH17 IGDCC4 CELSR2 PTPRS PCDH7	7.48e-06	85	111	6	int:TMEM30B
Interaction	H4C2 interactions	FN1 NASP MCM7 TRIM24 RLIM	1.18e-05	54	111	5	int:H4C2
Interaction	H4C13 interactions	FN1 NASP MCM7 TRIM24 RLIM	1.68e-05	58	111	5	int:H4C13
Interaction	RAC2 interactions	EPHB4 NR2C2 VASN NOL6 DAG1 KANK2 MFF PCDH17 CSNK1G3 SYNE2 PALM MACF1 PCDH7 USP6NL	2.02e-05	674	111	14	int:RAC2
Interaction	RYK interactions	EPHB4 PCDHB2 DAG1 PCDH17 IGDCC4 CELSR2 PTPRS PCDH7	2.29e-05	212	111	8	int:RYK
Interaction	RHOU interactions	EPHB4 VASN NOL6 MCM5 PCDH17 PTPRS CSNK1G3 GLS PALM MACF1 PCDH7 USP6NL	2.47e-05	510	111	12	int:RHOU
Interaction	NXPH2 interactions	VGF MADD CELSR2 PCDH7	3.15e-05	33	111	4	int:NXPH2
Interaction	H4C6 interactions	FN1 NASP MCM7 TRIM24 RLIM	3.93e-05	69	111	5	int:H4C6
Interaction	TOP3B interactions	EPHB4 HSPG2 SETD1B MCM5 ANKLE1 KAT2A MED13L KANK2 DENND1A MADD TAOK2 CELSR2 SLC16A5 ARVCF PTPRS PLEKHO2 MTHFR MDC1 EIF4G1 PALM SNAPC4	4.64e-05	1470	111	21	int:TOP3B
Interaction	H3C10 interactions	NASP MCM7 TRIM24 RLIM	5.57e-05	38	111	4	int:H3C10
Interaction	RHOB interactions	EPHB4 VASN NOL6 DAG1 KANK2 PCDH17 AP2M1 ARVCF PTPRS PLEKHO2 CSNK1G3 PALM MACF1 PCDH7 USP6NL	5.73e-05	840	111	15	int:RHOB
Interaction	LHX3 interactions	NR2C2 TRIM24 KANK2 ZNF587 SYNE2 RLIM ZNF417	7.45e-05	185	111	7	int:LHX3
Interaction	CDH1 interactions	CAMK1D VASN DAG1 KANK2 CRYAB AP2M1 ARVCF PTPRS PLEKHO2 PTPRQ EIF4G1 PALM3 MACF1 USP6NL	8.30e-05	768	111	14	int:CDH1
Interaction	BBS7 interactions	KANK2 MADD PLEKHO2 PWP2 MIOS	1.07e-04	85	111	5	int:BBS7
Interaction	FLRT1 interactions	VASN PCDH17 CELSR2 PCDH7	1.19e-04	46	111	4	int:FLRT1
Interaction	RHOH interactions	EPHB4 SPNS1 VASN DAG1 KANK2 MFF PCDH17 AP2M1 PTPRS PCDH7 USP6NL	1.23e-04	512	111	11	int:RHOH
Interaction	H3C1 interactions	NR2C2 SETD1B NOL6 SMC6 NASP MCM5 MCM7 KAT2A NEB MORC2 TRIM24 TMEM132D MDC1 RLIM EIF4G1	1.25e-04	901	111	15	int:H3C1
Interaction	H3C4 interactions	NASP TRIM24 RLIM	1.48e-04	19	111	3	int:H3C4
Interaction	RAC3 interactions	EPHB4 VASN DAG1 MFF PCDH17 AP2M1 PTPRS CSNK1G3 PALM MACF1 PCDH7 USP6NL	1.57e-04	619	111	12	int:RAC3
Interaction	RND2 interactions	EPHB4 VASN NOL6 MFF PCDH17 PTPRS CSNK1G3 SYNE2 PCDH7 USP6NL	1.61e-04	440	111	10	int:RND2
Interaction	H4C3 interactions	FN1 NASP TRIM24 RLIM	1.65e-04	50	111	4	int:H4C3
Interaction	RHOQ interactions	EPHB4 VASN DAG1 PCDH17 PTPRS CSNK1G3 PALM ZNF417 PCDH7 USP6NL	1.67e-04	442	111	10	int:RHOQ
Interaction	ACSM2B interactions	ACSM2A ACSM2B	1.79e-04	4	111	2	int:ACSM2B
GeneFamily	Fibronectin type III domain containing	EPHB4 COL7A1 FN1 IGDCC4 PTPRS PTPRQ TNXB	4.08e-06	160	74	7	555
GeneFamily	Acyl-CoA synthetase family	ACSM3 ACSM2A ACSM2B	1.60e-04	26	74	3	40
GeneFamily	MCM family	MCM5 MCM7	5.84e-04	9	74	2	1085
GeneFamily	Non-clustered protocadherins	PCDH17 PCDH7	1.06e-03	12	74	2	21
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRS PTPRQ	3.30e-03	21	74	2	813
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 COL6A3 FN1 NHSL2 DCLRE1B KANK2 TAOK2 ZNF417 TNXB	4.38e-10	166	113	9	9d4b44eb56ad38c26aed73444edf389abca6bdf6
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNFSF14 TAPBPL KANK2 KIF24 TUBGCP6 SLC16A5 MACF1 YME1L1	3.32e-08	192	113	8	930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNFSF14 TAPBPL KANK2 KIF24 TUBGCP6 SLC16A5 MACF1 YME1L1	3.32e-08	192	113	8	c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	USP18 NEB DENND1A PNPT1 MLXIPL OASL SLC17A8	1.25e-07	152	113	7	18194f757d319958f26e5a91f56d89f25711236f
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 FN1 NHSL2 PTPRS MACF1 PCDH7 TNXB	6.31e-07	193	113	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNFSF14 TAPBPL KIF24 TUBGCP6 SLC16A5 MACF1 YME1L1	6.53e-07	194	113	7	3211d89440a6f4a9b3d4cfb755890816944242ec
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 VASN CRYAB PTPRS MACF1 TNXB	6.99e-07	196	113	7	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 VASN CRYAB PTPRS MACF1 TNXB	6.99e-07	196	113	7	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 VASN CRYAB PTPRS MACF1 TNXB	7.24e-07	197	113	7	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL6A3 FN1 VASN KANK2 CRYAB PALM TNXB	8.01e-07	200	113	7	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL6A3 FN1 VASN KANK2 CRYAB PALM TNXB	8.01e-07	200	113	7	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	5'-Adult-LargeIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 FN1 VASN KANK2 CRYAB PCDH7 TNXB	8.01e-07	200	113	7	5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAPBPL SLC43A1 NASP MDC1 USP6NL RASGRP2	3.16e-06	158	113	6	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL7A1 NAP1L3 PERM1 KANK2 PTPRQ CNTNAP2	4.20e-06	166	113	6	1f39c7507ac6881aa1a30f8be22f98a1837d926b
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCLO PERM1 ADAM29 NEB MLXIPL TMEM132D	4.98e-06	171	113	6	fa5cc720bd0045d0307439be547b41d56def5b43
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NASP MCM5 MCM7 ANKLE1 E2F8 TACC3	6.07e-06	177	113	6	8a74f5e72de605774111057bd87a7e7e4a6385cd
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 KANK2 PTPRS RIMS1 PCDH7 TNXB	6.48e-06	179	113	6	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM5 MCM7 ANKLE1 KIF24 E2F8 TACC3	7.35e-06	183	113	6	42dc31d587fbb9724b2f0be5ee8ed77233f67b86
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 FN1 VASN PALM TNXB ACSM2B	8.06e-06	186	113	6	a7ab70b049742dfe7ee30557031bfac6412edf52
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL6A3 FN1 NHSL2 PTPRS MACF1 TNXB	8.31e-06	187	113	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	USP18 FN1 PNPT1 OASL CNTNAP2 USP6NL	8.31e-06	187	113	6	72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 KANK2 CRYAB ACSM3 RIMS1 PCDH7	8.57e-06	188	113	6	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 VASN IGDCC4 PTPRS PALM TNXB	8.83e-06	189	113	6	d531399749409d614adca13d181830c6e3287508
ToppCell	NS-critical-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EPHB4 MCM7 KANK2 KIF24 E2F8 CNTNAP2	9.10e-06	190	113	6	7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 NHSL2 PTPRS MACF1 PCDH7 TNXB	9.38e-06	191	113	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 NHSL2 PTPRS MACF1 PCDH7 TNXB	9.66e-06	192	113	6	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	COL6A3 TNFSF14 IGDCC4 PTPRS PALM TNXB	9.66e-06	192	113	6	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MED13L DENND1A SYNE2 MACF1 ACSM2A ACSM2B	9.66e-06	192	113	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO NEB MADD TAOK2 MLXIPL EIF4G1	9.95e-06	193	113	6	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 COL6A3 FN1 VASN CRYAB TNXB	9.95e-06	193	113	6	428b1a3ad87dff7f65de5161d40f102572a9341b
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 NHSL2 PTPRS MACF1 PCDH7 TNXB	9.95e-06	193	113	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO NEB MADD TAOK2 MLXIPL EIF4G1	9.95e-06	193	113	6	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 COL6A3 FN1 VASN CRYAB TNXB	9.95e-06	193	113	6	eff718664fe0aaf89050efd9cc7b6dfb1df46666
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL6A3 FN1 NHSL2 PTPRS CNTNAP2 PCDH7	9.95e-06	193	113	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EPHB4 MCM7 KANK2 E2F8 CNTNAP2 TACC3	9.95e-06	193	113	6	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.02e-05	194	113	6	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.02e-05	194	113	6	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 CRYAB PTPRS MACF1 TNXB	1.06e-05	195	113	6	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 CRYAB PTPRS MACF1 TNXB	1.06e-05	195	113	6	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 CRYAB PTPRS MACF1 TNXB	1.09e-05	196	113	6	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 FN1 NHSL2 PTPRS PCDH7 TNXB	1.09e-05	196	113	6	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NASP MCM5 MCM7 ANKLE1 E2F8 TACC3	1.09e-05	196	113	6	5ddd314d3def3776dc7da83778d41c6436ca51ac
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.12e-05	197	113	6	16758f181ef07c60aee63072e1da9572c5c85414
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 VASN KANK2 CRYAB PALM TNXB	1.12e-05	197	113	6	c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 FN1 CRYAB PTPRS MACF1 TNXB	1.12e-05	197	113	6	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / Treatment groups by lineage, cell group, cell type	HSPG2 KIF24 E2F8 ZNF587 RLIM TACC3	1.12e-05	197	113	6	038fd92750257d43d5e980fd06d77742b543f11a
ToppCell	Epithelial_cells-Epithelial_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DMGDH CRYAB ACSM3 PALM ACSM2A ACSM2B	1.15e-05	198	113	6	52e9d41a1726bc1140df6baec9f17a534448ac8b
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 COL6A3 DAG1 IGDCC4 CRYAB TNXB	1.15e-05	198	113	6	5e70246a9ce199cb2fb5379912b8ab59456219e4
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 COL6A3 FN1 VASN CRYAB TNXB	1.15e-05	198	113	6	1b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCell	Epithelial_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DMGDH CRYAB ACSM3 PALM ACSM2A ACSM2B	1.15e-05	198	113	6	eeec789d226171f30799577cc37c07bdced2e3cb
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 COL6A3 FN1 KANK2 CRYAB PTPRS	1.18e-05	199	113	6	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	USP18 DAG1 NEB IGDCC4 CRYAB PCDH7	1.18e-05	199	113	6	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 FN1 KANK2 CRYAB ACSM3 TNXB	1.18e-05	199	113	6	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB4 HSPG2 FN1 NHSL2 PCDH17 TNXB	1.18e-05	199	113	6	da5a88749d859d535daa030d0974485906cc0ba7
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A3 FN1 CRYAB PTPRS MACF1 TNXB	1.18e-05	199	113	6	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 FN1 CRYAB PTPRS MACF1 TNXB	1.18e-05	199	113	6	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 FN1 CRYAB PTPRS MACF1 TNXB	1.18e-05	199	113	6	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	(2)_Fibroblasts-(24)_Fibro-5\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL6A3 CAMK1D FN1 KANK2 CRYAB TNXB	1.18e-05	199	113	6	6c0354f57883330c685a8d9d5d3014ace7eca584
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	USP18 DAG1 NEB IGDCC4 CRYAB PCDH7	1.18e-05	199	113	6	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	NASP MCM5 MCM7 E2F8 SYNE2 TACC3	1.22e-05	200	113	6	8f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells\|10w / Sample Type, Dataset, Time_group, and Cell type.	NASP MCM5 MCM7 E2F8 SYNE2 TACC3	1.22e-05	200	113	6	a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCell	medial-mesenchymal-Alveolar_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A3 FN1 VASN CRYAB PTPRS MACF1	1.22e-05	200	113	6	c22cbfecee00183dd4be678f116ab9fd9ad0a4dd
ToppCell	390C-Fibroblasts-Fibroblast-H-\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 FN1 VASN KANK2 CRYAB PTPRS	1.22e-05	200	113	6	ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd
ToppCell	343B-Fibroblasts\|343B / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.22e-05	200	113	6	376c1a77031e090be96948b47c78ac0d393f5775
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.22e-05	200	113	6	db6281b5d4032116310db379d9175d790994c99c
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 FN1 NHSL2 PTPRS PCDH7 TNXB	1.22e-05	200	113	6	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 FN1 NHSL2 PTPRS PCDH7 TNXB	1.22e-05	200	113	6	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	(5)_Fibroblasts\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.22e-05	200	113	6	22c839f27d3abdf86bfabdfa305f205dd899a9dc
ToppCell	medial-2-mesenchymal-Alveolar_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A3 FN1 VASN CRYAB PTPRS MACF1	1.22e-05	200	113	6	cc6062dac07916c29091fc6bee2b864d29e6525b
ToppCell	Parenchymal-10x3prime_v2-Stromal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.22e-05	200	113	6	f6be0f24e607abb9007823a54fb0b24d04990a89
ToppCell	medial-mesenchymal-Alveolar_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A3 FN1 VASN CRYAB PTPRS MACF1	1.22e-05	200	113	6	5c0716bf375c8158f7dc2c82bf5eaf37af594dd0
ToppCell	Parenchyma_Control_(B.)-Stromal-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL6A3 VASN KANK2 CRYAB PALM TNXB	1.22e-05	200	113	6	0a86656d48e4238d0e4d592d477d29f7ba7c2ec0
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 FN1 NHSL2 PTPRS PCDH7 TNXB	1.22e-05	200	113	6	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Tracheal-10x3prime_v2-Stromal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.22e-05	200	113	6	f74b9b0e27afedd589e828d30194e8417029817a
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 VASN KANK2 CRYAB PALM TNXB	1.22e-05	200	113	6	3fa7d9ea67f9cc55478d085da53babd03dbe9bb1
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 VASN KANK2 CRYAB PALM TNXB	1.22e-05	200	113	6	74ad0ae592252060ee294d7483327d765a6ba1dd
ToppCell	tumor_Lung-Fibroblasts\|tumor_Lung / Location, Cell class and cell subclass	COL6A3 FN1 VASN KANK2 CRYAB TNXB	1.22e-05	200	113	6	073a68b5ce232203ffee86342cba2a00d907e119
ToppCell	Sigmoid-(1)_T_cell-(18)_cycling_gd_T\|Sigmoid / shred on region, Cell_type, and subtype	DAG1 DCLRE1B E2F8 TUBGCP6 TACC3 MAN1B1	1.22e-05	200	113	6	6e367abd1a4b87e20eb9095b8337723163e8bbae
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 FN1 NHSL2 PTPRS PCDH7 TNXB	1.22e-05	200	113	6	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 FN1 NHSL2 PTPRS PCDH7 TNXB	1.22e-05	200	113	6	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Lung_Parenchyma-Control-Mesenchymal\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A3 VASN KANK2 CRYAB PALM TNXB	1.22e-05	200	113	6	1e75d1302c22e1b1666c19c0c9259d5cc8be16d5
ToppCell	390C-Fibroblasts-Fibroblast-H\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 FN1 VASN KANK2 CRYAB PTPRS	1.22e-05	200	113	6	671e731977c58a0c44c36b56422085d93d999aad
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 VASN KANK2 CRYAB PALM TNXB	1.22e-05	200	113	6	7ba292c30d915e66ebc8026fa76492cedf64700e
ToppCell	normal_Lung-Fibroblasts-COL14A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	COL6A3 VASN CRYAB PTPRS PALM TNXB	1.22e-05	200	113	6	ee3d06865a6300e1279edf6664320b71647f5efb
ToppCell	Sigmoid-T_cell-cycling_gd_T\|Sigmoid / Region, Cell class and subclass	DAG1 DCLRE1B E2F8 TUBGCP6 TACC3 MAN1B1	1.22e-05	200	113	6	9769185abae084ffac36420c749625e679b70ca8
ToppCell	NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	USP18 TNFRSF10D PNPT1 OASL CNTNAP2	4.45e-05	153	113	5	859de35b24c5d7d73be1c213b90b43362ee2e0eb
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	COL6A3 FN1 NHSL2 PTPRS TNXB	5.34e-05	159	113	5	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB4 HSPG2 FN1 NHSL2 ACSM2A	5.50e-05	160	113	5	33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL6A3 FN1 MED13L CNTNAP2 MACF1	6.01e-05	163	113	5	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	Control-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	FN1 THSD8 MED13L MLXIPL OASL	7.33e-05	170	113	5	9e328e1f904c77dcce8aee4df775d7f0ac725775
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FN1 NASP MCM5 MCM7 MACF1	7.33e-05	170	113	5	e20568c8f3f17d94de78229617eb2f7e4c5af2bc
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC43A1 MCM5 ANKLE1 E2F8 TACC3	7.54e-05	171	113	5	ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MCM7 FAM170A TAB3 PWP2 TACC3	7.54e-05	171	113	5	f1fdc0ec3399ed6955976d02be7e5fc329a64276
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC43A1 MCM5 ANKLE1 E2F8 TACC3	7.75e-05	172	113	5	95219814e37259e34be053572cc95d4639360c27
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NASP MCM7 ANKLE1 KIF24 E2F8	7.75e-05	172	113	5	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MCM5 MCM7 ANKLE1 E2F8 TACC3	7.96e-05	173	113	5	c399786aa25bdbe3394988db6955842b5b7e6b41
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCM5 MCM7 ANKLE1 E2F8 TACC3	7.96e-05	173	113	5	31784679190fbd95fc23d7c66008eb21b8c7cc5d
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NASP MCM5 E2F8 PCDH17 TACC3	8.18e-05	174	113	5	c988471207ba06195bc3e41056435e8c31c20bbe
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	COL7A1 FN1 VASN KANK2 MADD	8.18e-05	174	113	5	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NASP MCM5 MCM7 E2F8 PCDH17	8.18e-05	174	113	5	66555c610251ea04f968c258e312d720c18e7cde
Drug	Lt 3	FN1 TMEM132D MTHFR	3.89e-06	7	111	3	CID000217025
Drug	Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	PCLO DAG1 ADAM29 TAOK2 PTPRS MTHFR CNTNAP2 RASGRP2	5.41e-06	196	111	8	4825_UP
Disease	X-21319 measurement	ACSM2A ACSM2B	1.35e-05	2	109	2	EFO_0800807
Disease	X-11478 measurement	ACSM2A ACSM2B	4.05e-05	3	109	2	EFO_0021242
Disease	dextro-looped transposition of the great arteries (is_implicated_in)	MED13L MTHFR	4.05e-05	3	109	2	DOID:0060770 (is_implicated_in)
Disease	cholesterol to total lipids in large HDL percentage	DMGDH MADD MLXIPL CELSR2	5.20e-05	55	109	4	EFO_0022234
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	DMGDH MLXIPL CELSR2 SYNE2 MACF1	8.87e-05	121	109	5	EFO_0008595, EFO_0020943
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	DMGDH MLXIPL CELSR2 SYNE2 MACF1	1.11e-04	127	109	5	EFO_0008595, EFO_0020947
Disease	3-hydroxyhexanoate measurement	ACSM2A ACSM2B	1.34e-04	5	109	2	EFO_0800378
Disease	free cholesterol to total lipids in large LDL percentage	DMGDH MLXIPL CELSR2 MACF1	1.66e-04	74	109	4	EFO_0022280
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	MADD MLXIPL CELSR2 SYNE2 MACF1	2.01e-04	144	109	5	EFO_0004611, EFO_0020943
Disease	Congenital muscular dystrophy (disorder)	DAG1 SYNE2	2.01e-04	6	109	2	C0699743
Disease	indoleacetylglutamine measurement	ACSM3 ACSM2A	2.01e-04	6	109	2	EFO_0800035
Disease	indoleacetoylcarnitine measurement	ACSM2A ACSM2B	2.01e-04	6	109	2	EFO_0800106
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	DMGDH MLXIPL CELSR2 SYNE2 MACF1	2.43e-04	150	109	5	EFO_0004611, EFO_0020947
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	ZC3H14 CNTNAP2	3.73e-04	8	109	2	DOID:0060308 (implicated_via_orthology)
Disease	X-17676 measurement	ACSM3 ACSM2B	3.73e-04	8	109	2	EFO_0800785
Disease	triglycerides in large LDL measurement	MLXIPL CELSR2 SYNE2	5.43e-04	43	109	3	EFO_0022319
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	DMGDH MLXIPL CELSR2 SYNE2 MACF1	8.99e-04	200	109	5	EFO_0004611, EFO_0020945
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	PNPT1 PTPRQ	1.03e-03	13	109	2	C1846647
Disease	Small cell carcinoma of lung	TTBK2 TMEM132D CNTNAP2	1.06e-03	54	109	3	C0149925
Disease	triglycerides in LDL measurement	MLXIPL CELSR2 SYNE2	1.18e-03	56	109	3	EFO_0022320
Disease	beta-hydroxyisovalerate measurement	ACSM3 ACSM2B	1.20e-03	14	109	2	EFO_0800125
Disease	5-methyluridine (ribothymidine) measurement	PCLO PTPRS	1.20e-03	14	109	2	EFO_0020013
Disease	triglycerides to total lipids in small VLDL percentage	DMGDH MLXIPL CELSR2	1.31e-03	58	109	3	EFO_0022338
Disease	triglycerides to total lipids in small LDL percentage	DMGDH MLXIPL CELSR2	1.37e-03	59	109	3	EFO_0022337
Disease	cholesteryl esters to total lipids in large HDL percentage	MADD MLXIPL CELSR2	1.37e-03	59	109	3	EFO_0022248
Disease	Intellectual Disability	ZC3H14 MED13L PNPT1 AP2M1 RLIM MACF1 MAN1B1	1.38e-03	447	109	7	C3714756
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	DMGDH MLXIPL CELSR2 SYNE2 MACF1	1.43e-03	222	109	5	EFO_0008317, EFO_0020943
Disease	free cholesterol to total lipids in medium HDL percentage	MADD MLXIPL CELSR2	1.44e-03	60	109	3	EFO_0022282
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	DMGDH MLXIPL CELSR2 SYNE2 MACF1	1.49e-03	224	109	5	EFO_0004530, EFO_0008317
Disease	nervousness	DENND1A MADD	1.57e-03	16	109	2	NCIT_C74532
Disease	phospholipids:total lipids ratio	DMGDH MADD MLXIPL CELSR2 MACF1	1.57e-03	227	109	5	EFO_0020946
Disease	serum albumin measurement	COL7A1 KAT2A ALKBH5 MADD MLXIPL CSNK1G3 MACF1 PCDH7	1.62e-03	592	109	8	EFO_0004535
Disease	triglycerides to total lipids in IDL percentage	DMGDH MLXIPL CELSR2	1.66e-03	63	109	3	EFO_0022329
Disease	triglycerides to total lipids in medium VLDL percentage	DMGDH MLXIPL CELSR2	1.66e-03	63	109	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	DMGDH MLXIPL CELSR2	1.66e-03	63	109	3	EFO_0022239
Disease	cholesteryl esters to total lipids in medium VLDL percentage	DMGDH MLXIPL CELSR2	1.73e-03	64	109	3	EFO_0022253
Disease	response to radiation, Urinary retention	COL6A3 PTPRS	1.77e-03	17	109	2	GO_0009314, HP_0000016
Disease	total lipids in very large HDL measurement	MADD MLXIPL CELSR2	1.89e-03	66	109	3	EFO_0022312
Disease	FEV/FEC ratio	HSPG2 COL6A3 CAMK1D NASP MCM7 NEB ARVCF PLEKHO2 CROCC2 SYNE2 CNTNAP2 TNXB	1.95e-03	1228	109	12	EFO_0004713
Disease	cholesterol to total lipids in very small VLDL percentage	DMGDH MLXIPL CELSR2	1.98e-03	67	109	3	EFO_0022245
Disease	serum gamma-glutamyl transferase measurement	DMGDH TNFSF14 PERM1 MLXIPL CELSR2 CSNK1G3 OASL SLC17A8 PALM3 USP6NL	2.08e-03	914	109	10	EFO_0004532
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	DMGDH MADD MLXIPL CELSR2 MACF1	2.12e-03	243	109	5	EFO_0004612, EFO_0020944
Disease	triglycerides to total lipids in very small VLDL percentage	DMGDH MLXIPL CELSR2	2.15e-03	69	109	3	EFO_0022341
Disease	cholesterol in very large HDL measurement	MADD MLXIPL CELSR2	2.15e-03	69	109	3	EFO_0022229
Disease	X-11470 measurement	VARS2 TNXB	2.22e-03	19	109	2	EFO_0021241
Disease	autism spectrum disorder (implicated_via_orthology)	TAOK2 ARVCF CNTNAP2 RIMS1	2.48e-03	152	109	4	DOID:0060041 (implicated_via_orthology)
Disease	unipolar depression, bipolar disorder	PCLO DENND1A TUBGCP6 SYNE2	2.72e-03	156	109	4	EFO_0003761, MONDO_0004985
Disease	free cholesterol to total lipids in small VLDL percentage	DMGDH MLXIPL CELSR2	2.73e-03	75	109	3	EFO_0022287
Disease	fat intake measurement	NOL6 MLXIPL	2.98e-03	22	109	2	EFO_0010809
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	DMGDH MLXIPL CELSR2 SYNE2 MACF1	3.03e-03	264	109	5	EFO_0008317, EFO_0020944
Disease	apolipoprotein B measurement	FN1 PUM2 KANK2 MLXIPL CELSR2 CSNK1G3 SYNE2 BLOC1S3	3.24e-03	663	109	8	EFO_0004615
Disease	squamous cell lung carcinoma	VARS2 NEB RIMS1 TNXB	3.33e-03	165	109	4	EFO_0000708
Disease	complex trait	EPHB4 TAOK2 MLXIPL OASL MACF1	3.39e-03	271	109	5	EFO_0010578
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	DMGDH MADD MLXIPL CELSR2 MACF1	3.66e-03	276	109	5	EFO_0004612, EFO_0020943

Protein segments in the cluster

Peptide	Gene	Start	Entry
PDVVIPVRITGTTRG	ADAM29	31	Q9UKF5
RAVPVVSRTTPGIVT	CCDC187	686	A0A096LP49
RTRTRIGAETQEPEP	ANKLE1	136	Q8NAG6
VTTRTVRQVPVGPDG	ARVCF	131	O00192
EPVLSLPVRRGSVTV	ALKBH5	241	Q6P6C2
TAVISSPDPVRGEVV	ACSM2A	491	Q08AH3
APEETVPTGTRQQLI	CFAP46	846	Q8IYW2
VQVREDVTPGAPVLR	CELSR2	406	Q9HCU4
RPRTQGVVFESPEES	DCLRE1B	346	Q9H816
AVVVREGLPSAPTRV	IGDCC4	421	Q8TDY8
ITGTEPRIIRDPEAQ	NWD2	281	Q9ULI1
ISRDQSTPIIEVEGP	NR2C2	346	P49116
TTPSRREITGVQAQP	PALM	266	O75781
PPGTVIALVRVTDRD	PCDH17	366	O14917
VGSRLRIPQVTPADS	HSPG2	2581	P98160
PIRIESSSPTVVEGQ	HSPG2	2631	P98160
QVSGPERTIPITREE	CRYAB	151	P02511
RQIPVESVPGIRETG	KAT2A	701	Q92830
PGSRQASPTEVVERL	PUM2	176	Q8TB72
PITGERVLSPEAVRN	GLS	441	O94925
EIGRVPEVVQTSSPR	PALM3	291	A6NDB9
SPPRSGTALVRIEVV	PCDHB2	221	Q9Y5E7
GREIIQPTVVDPVSF	MTHFR	566	P42898
RSPVPVSGQKRVDIE	MADD	256	Q8WXG6
ESVTERERIGIPTEP	MED13L	1651	Q71F56
SRGPLTVEETPRVQG	MDC1	141	Q14676
SRRETIPQVQSSGVP	PSMG3-AS1	166	Q96PY0
REVPPAVSDIRVTRS	EPHB4	431	P54760
GSRPPEIREEEVQTV	RASGRP2	586	Q7LDG7
PTTPQNEEIRAVGRL	MFF	136	Q9GZY8
TRPRPSGEEVLQDIQ	MCM5	111	P33992
VRGTSENLPERSVPL	SLC43A1	281	O75387
PTVTIRTRGAIIQTP	DAG1	366	Q14118
VQTEPVGTIRTPSIR	PCLO	3526	Q9Y6V0
PVLTLTVEENRPVGT	PCDH7	146	O60245
EVNQRVVRVPSVPET	NOL6	111	Q9H6R4
TPLREVSADGPIQVT	KIF24	1006	Q5T7B8
RATVPAVTVSVPEGT	MACF1	906	O94854
RVGENVSDVAPTRPR	TUBGCP6	1116	Q96RT7
VKPTRTRVVSEVQRP	FMO6P	501	O60774
EVRIPTPLNTSGVQV	AP2M1	321	Q96CW1
GRSNAPITAPTEVEV	CSNK1G3	411	Q9Y6M4
VGDQTPIEPQTSIER	NASP	386	P49321
SDQVPVGNIPRSITV	MCM7	241	P33993
AVIEPEQGTELPSRR	MAN1B1	211	Q9UKM7
EQGTELPSRRAEVPT	MAN1B1	216	Q9UKM7
EVTTRPSTEEPVRRP	MORC2	596	Q9Y6X9
QTRGTAEPITVTIVP	OASL	141	Q15646
EGPPTVLSVRTRQQV	PTPRQ	596	Q9UMZ3
VVVRTDEDVPSAPPR	PTPRS	711	Q13332
SEPQVEIIVSRPIGD	RIMS1	681	Q86UR5
VPEAPVGRSTLQEVV	IGSF8	206	Q969P0
SGIVPVSPRIESVNV	E2F8	756	A0AVK6
TPVPTRIREIVAGSL	CROCC2	56	H7BZ55
EVSPVEIPGQTLRTA	ERICH4	26	A6NGS2
PVVIQQETTGTPRSD	FN1	891	P02751
QGVVTTLENVSPPRR	FN1	1896	P02751
RVSVVANTPSGPVEA	COL6A3	1886	P12111
LRRPETVVPGEATET	BLOC1S3	11	Q6QNY0
GETPQVAVIVRPDDR	EIF4G1	221	Q04637
QPGSIRLATTPVRVD	DMGDH	131	Q9UI17
NIAVEGRRTSVPSPE	DENND1A	511	Q8TEH3
PDSPVRVDTVRVVEG	KANK2	321	Q63ZY3
SVVVRTAPEPVGRVS	COL7A1	766	Q02388
DVGNGPVEIVVRSPT	CNTNAP2	861	Q9UHC6
STPVPVTEQGTDQIR	PERM1	256	Q5SV97
TTRPETLPGDVAVAV	VARS2	336	Q5ST30
PPEVTGRSSVLRVSQ	TACC3	26	Q9Y6A5
TLTRVNLESPGPERV	VGF	191	O15240
STQVVPPERRTALGV	TAPBPL	396	Q9BX59
EEETESRVPGSTRPQ	SYNE2	6811	Q8WXH0
PTVVAGRRKSVDQPE	TMEM132D	206	Q14C87
IEITVEPSQRPGTAI	TAB3	366	Q8N5C8
SIEVEAREISSPGRP	NHSL2	691	Q5HYW2
TIPEVSSVPDQIRGE	NBR1	841	Q14596
PLRDVTNRPEVGSTV	RIC8B	391	Q9NVN3
VPSLVPQERSIVGQE	TAOK2	851	Q9UL54
SNRPVEIVEDPRVVG	SETD1B	61	Q9UPS6
TTATGEIEIQPRVVP	NAP1L3	421	Q99457
PRASRKENGPVVETV	PNPT1	596	Q8TCS8
DPGRIPEQATRAVTE	MLXIPL	831	Q9NP71
VGAERRPRPTTVTAV	CAMK1D	366	Q8IU85
TAVISSPDPVRGEVV	ACSM2B	491	Q68CK6
SAVVSSPDPIRGEVV	ACSM3	506	Q53FZ2
VRVDSATIPRQDEVP	TNFRSF10D	51	Q9UBN6
EEVSPEAVGVTSQRP	TRIM24	206	O15164
RIGVQPSPERRSEVV	nan	21	Q9BTK2
AVTVPGPAEVRVSNV	USP6NL	516	Q92738
GDETEPTIIERSVQP	MIOS	306	Q9NXC5
GAIIRPVATSVAPET	SLC16A5	186	O15375
GPEETITQQGRTPRT	SARG	96	Q9BW04
VRPSVFVVDGQTDIP	TNFSF14	6	O43557
AVPRGEIEVVTSSLP	PWP2	781	Q15269
VVPQRGRSTRVPVAS	SPNS1	511	Q9H2V7
TEALTEVPPTRGQRR	RLIM	196	Q9NVW2
PRRPTQQGTVTFEDV	ZNF587	6	Q96SQ5
GSPIRVRSEITQPDR	TTBK2	421	Q6IQ55
DGPQDLRVVAVTPTT	TNXB	841	P22105
VPVEGPQRSAVITSL	TNXB	1106	P22105
QVVPVEGPERSFVVS	TNXB	1201	P22105
QPQVVPVEGSLREVS	TNXB	1816	P22105
RRVGPVSTVGVTAPQ	TNXB	2486	P22105
RRVGPVSTVGVTAPE	TNXB	2811	P22105
VVRVGTPPSDVSTRN	FAM170A	166	A1A519
PRRPTQQGTVTFEDV	ZNF417	6	Q8TAU3
RIRTENGSILPSVVP	ZNF654	1001	Q8IZM8
EETPSEQRISGERVP	ZNF211	81	Q13398
ERGQTTLPFRPVTQE	SMC6	1071	Q96SB8
GERPVVQRREPVSLE	TBC1D15	306	Q8TC07
RQGTTVPRDVPPDTV	VASN	41	Q6EMK4
QVTVPRPDVKGRTEI	YME1L1	501	Q96TA2
ITVPRGADEQRRSVP	USP41	86	Q3LFD5
QSVSVEGVPQVRTPE	ZNF416	81	Q9BWM5
GEAQVAREIPEPRTS	SNAPC4	1176	Q5SXM2
RVETPVGERAPTPVS	PLEKHO2	221	Q8TD55
ITVPRGADEQRRSVP	USP18	86	Q9UMW8
LSVRQESVEPQPRGV	ZSCAN29	131	Q8IWY8
VTVIPTERSRLGVGP	TMEM202	226	A6NGA9
AEVVQGQSRTPRISP	ZC3H14	396	Q6PJT7
QERSREVVGTAPGPV	THSD8	71	A0A1W2PP97
KRGEVVTIRVPTHPE	TMED8	186	Q6PL24
NVRRVEGTVPPDVLV	USP17L10	451	C9JJH3
IELNEEGRPVQTSRP	SLC17A8	46	Q8NDX2
GTGIPTTVTPEIERV	NEB	6221	P20929